Sabaté O, Campion D, d'Amato T, Martres M P, Sokoloff P, Giros B, Leboyer M, Jay M, Guedj F, Thibaut F
Laboratoire de génétique Moléculaire de la Neurotransmission et des Processus Neurodégénératifs; CHS du Rouvray, Sotteville les Rouen, France.
Am J Psychiatry. 1994 Jan;151(1):107-11. doi: 10.1176/ajp.151.1.107.
This study was performed to assess the possible involvement of the dopamine D3 receptor gene (DRD3) in the etiology of schizophrenia. The authors' approach included a population study and a family study using both parametric (lod score) and nonparametric (affected pedigree member) methods of linkage analysis.
Two different DNA markers were studied at the DRD3 locus. The family study included 35 multiplex families of schizophrenic subjects for the linkage analyses. The population study involved 50 unrelated schizophrenic subjects and 50 normal comparison subjects from the same ethnic and geographic origin.
Whichever clinical classification was used to define the pathological phenotype (schizophrenia or schizophrenia spectrum), the results of the lod score and affected pedigree member studies did not provide any evidence of linkage of the DRD3 gene to the illness. The negative results of the association study reinforce these results.
The hypothesis that the DRD3 gene has a predisposing role in schizophrenia was not supported by these population and family studies. However, the possibility that this gene has a role in the etiology of the disease cannot be definitely excluded because of the intrinsic limitations of the methods of analysis and the number of subjects studied.
本研究旨在评估多巴胺D3受体基因(DRD3)在精神分裂症病因学中可能的作用。作者的研究方法包括一项群体研究和一项家系研究,采用参数法(对数优势比分值)和非参数法(患病家系成员法)进行连锁分析。
在DRD3基因座研究了两种不同的DNA标记。家系研究包括35个精神分裂症患者的核心家系用于连锁分析。群体研究涉及50名无亲缘关系的精神分裂症患者和50名来自相同种族和地理区域的正常对照者。
无论采用何种临床分类来定义病理表型(精神分裂症或精神分裂症谱系),对数优势比分值研究和患病家系成员研究的结果均未提供DRD3基因与该疾病连锁的任何证据。关联研究的阴性结果进一步证实了这些结果。
这些群体和家系研究不支持DRD3基因在精神分裂症中具有易患作用这一假说。然而,由于分析方法的固有局限性和所研究的受试者数量,不能绝对排除该基因在疾病病因学中起作用的可能性。